Patent SG-11201407241Q-A (SG)
Title: Syringe
Inventor: BRYANT ANDREW
IPC: A61M5/315
Filed: 2013-05-30
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 5 December 2013 (05.12.2013) WIPOIPCT (10) International Publication Number WO 2013/178771 A1 (51) International Patent Classification: A61K 9/00 (2006.01) A61M 5/31 (2006.01) A61M 5/28 (2006.01) A61M 5/315 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/EP2013/061215 30 May 2013 (30.05.2013) English English (30) Priority Data: 12170628.7 1 June 2012 (01.06.2012) EP (71) Applicant (for all designated States except US): NO- VARTIS AG [CH/CH]; Lichtstrasse 35, CH-4056 Basel (CH). (72) Inventors; and (71) Applicants (for US only): BRYANT, Andrew [GB/CH]; c/o Novartis Pharma AG, Postfach, CH-4002 Basel (CH). BUETTGEN, Heinrich [DE/CH]; c/o Novartis Pharma AG, Postfach, CH-4002 Basel (CH). PAPST, Wolfgang [DE/CH]; c/o Novartis Pharma AG, Postfach, CH-4002 Basel (CH). PICCI, Marie [FR/CH]; c/o Novartis Pharma AG, Postfach, CH-4002 Basel (CH). (74) Agent: BONE, Alexander M.T.; Novartis Pharma AG, Patent Department, CH-4002 Basel (CH). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) Published: — with international search report (Art. 21(3)) (54) Title: SYRINGE 4£ ^ i> i> 00 l> zz. Fig 3 i-H o CJ (57) Abstract: The invention provides syringe a for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that front surface of a the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not move to the stopper away from the outlet end.